Edmonton, Canada

Wladyslaw A Budzynski

USPTO Granted Patents = 4 


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Vancouver, CA (2012)
  • Edmonton, CA (2010 - 2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wladyslaw A Budzynski: Innovator in Vaccine Development

Introduction

Wladyslaw A Budzynski is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of immunology, particularly in vaccine development. With a total of 4 patents, his work focuses on innovative solutions to modulate immune responses.

Latest Patents

Among his latest patents is a groundbreaking vaccine designed for modulating between T1 and T2 immune responses. This invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo. This advancement holds promise for enhancing vaccine efficacy and tailoring immune responses to specific health challenges.

Career Highlights

Wladyslaw A Budzynski has established a career marked by innovation and dedication to improving public health through his research. His work at Oncothyreon Inc. has positioned him at the forefront of vaccine technology, where he continues to explore new avenues for immune modulation.

Collaborations

He has collaborated with esteemed colleagues, including R Rao Koganty and Mark J Krantz, to further advance his research and development efforts. These partnerships have been instrumental in driving forward the innovative projects he is involved in.

Conclusion

Wladyslaw A Budzynski's contributions to vaccine development exemplify the impact of innovative thinking in the field of immunology. His work continues to pave the way for advancements that could significantly improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…